AXOGEN INC (AXGN) Stock News
NASDAQ:AXGN - Nasdaq - US05463X1063 - Common Stock - Currency: USD
AXGN Latest News, Press Relases and Analysis
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Craig Swandal, experienced medical device manufacturing executive, joins leadership team...
AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Axogen (NASDAQ:AXGN) just reported results for the second quarter of 2024.Axoge...
AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q2 2024
AXGN stock results show that Axogen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Craig Swandal, experienced medical device manufacturing executive, joins leadership team
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
ALACHUA, Fla. and TAMPA, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
AXGN Stock Earnings: Axogen Beats EPS, Misses Revenue for Q1 2024
AXGN stock results show that Axogen beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
ALACHUA, Fla. and TAMPA, Fla., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
ALACHUA, Fla. and TAMPA, Fla., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
CytoSorbents CFO Kathleen P. Bloch Retires
Mentions: CTSO
Axogen, Inc. Announces New Leadership Appointments
The Board of Directors appoints Michael Dale as new CEO and Director, effective August 9, 2024Dale replaces Karen Zaderej, who will remain in an advisory...
Axogen, Inc. Announces New Leadership Appointments
Axogen, Inc. Reports Second Quarter 2024 Financial Results
ALACHUA, Fla. and TAMPA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen, Inc. Reports Second Quarter 2024 Financial Results
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
ALACHUA and TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical...
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
ALACHUA, Fla. and TAMPA, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
ALACHUA, Fla. and TAMPA, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
Showcasing Axogen’s Dedication to Fueling Ohio’s Biotechnology Sector Growth...
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
Showcasing Axogen’s Dedication to Fueling Ohio’s Biotechnology Sector Growth
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
Axogen, Inc Reports First Quarter 2024 Financial Results
ALACHUA, Fla. and TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen, Inc Reports First Quarter 2024 Financial Results
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...